State kratom laws can be difficult to read because familiar words such as “kratom product,” “adulterated” and “retailer” carry their own legal definitions in each statute. This guide works through two recently enacted frameworks using their official text: the Rhode Island Kratom Act, enacted on July 2, 2025 and effective April 1, 2026, and Wyoming’s Senate File 56, whose enrolled text takes effect July 1, 2026. Both keep adult sales lawful while regulating how products are made, sold and inspected, but they use different tools, which makes them useful to compare. This is general education rather than legal advice, and readers should confirm current law for their own state.
Definitions come first because they decide what a law covers. Rhode Island defines a kratom product as one containing any part or extract of the kratom leaf, including concentrated forms and products that combine kratom with other ingredients. Wyoming defines it as a food or dietary supplement made from kratom leaf, leaf extract, or a kratom alkaloid, constituent or metabolite, and states that the term excludes synthesized and semi-synthesized alkaloids. Wyoming also names the solvents allowed for making leaf extract: water, ethanol, food-grade carbon dioxide, or another solvent permitted for food ingredients under federal or state law.
Both statutes separate traditional extraction from chemical alteration. Rhode Island’s definition of synthesized material covers alkaloids created by chemical synthesis or biosynthetic means, or exposed to processes that structurally change them, while excluding traditional food-preparation techniques such as heating or extracting. Wyoming’s language is close, describing semi-synthesized alkaloids as those changed by processes such as oxidation, reduction, and ring opening and closing. That boundary between leaf, extract and chemically altered material is one of the central ideas in current kratom policy, and in these laws it determines which products may lawfully be sold.
Composition limits are the next feature to read closely. Rhode Island bans products containing synthetic alkaloids, including synthetic mitragynine and synthetic 7-hydroxymitragynine, and bars any product in which 7-hydroxymitragynine exceeds one percent of total kratom alkaloids. Wyoming sets its ceiling at two percent of a product’s alkaloid composition and separately prohibits adulteration, which it defines as adding a controlled substance or a synthesized or semi-synthesized alkaloid. The thresholds differ because each legislature chose its own number, and applying either one requires laboratory analysis. Rhode Island lets its health department require independent third-party testing at the retailer’s expense, while Wyoming directs the state chemist to analyze products when law enforcement or the health department asks.
Age and retail rules are similar in aim. Both laws set 21 as the minimum age. Rhode Island requires photo identification for every purchase, keeps products behind the counter, limits retail sales to a licensed fixed location, and prohibits delivery to retail purchasers. Wyoming forbids displaying or storing products where people under 21 can reach them, offers retailers an affirmative defense if they reasonably relied on an identification card, and waives the fine for a first offense within 24 months when a retailer can show a written policy, employee training, identification checks and disciplinary sanctions. Both prohibit products that mimic candy, and both bar combustible or vaporized forms.
Package requirements are written into both laws as well. Rhode Island requires visible statements including a recommendation to consult a health care professional, a note that kratom may be habit forming, a pregnancy and breastfeeding statement, a medication-interaction warning, the standard federal disclaimer for supplements, net contents, and the manufacturer’s name and street address, and it requires child-resistant packaging. Wyoming requires a similar set: manufacturer name and address, a full ingredient list, advice against use by people under 21 or who are pregnant or breastfeeding, the same consult and interaction advice, a keep-out-of-reach-of-children statement, and directions for use with serving information and per-serving amounts of mitragynine and 7-hydroxymitragynine. These are statutory warnings written by legislators, not conclusions drawn by this publication.
Where the two laws diverge most is structure. Rhode Island builds a licensing system: manufacturers, importers, distributors and retailers must each hold an annual state license, with initial and renewal fees of $2,000 for manufacturers, importers and distributors and $1,000 for retailers from April 1, 2026 through December 31, 2027, after which the health department may set fees by rule. Retailers may buy only from licensed distributors, which closes the supply chain, and the act adds a 15 percent excise tax on wholesale cost. The enrolled Wyoming text contains no licensing scheme. It relies instead on criminal offences, laboratory testing and inspections.
Enforcement follows the same split. In Rhode Island, violations of the product and age rules can bring fines of up to $1,000 for a first offense and up to $2,000 for a second, with license revocation on a third; selling without a license carries a $5,000 fine; and noncompliant products are treated as contraband that may be seized. Affected parties can request a hearing and appeal to district court within 30 days. In Wyoming, a violation is a misdemeanor punishable by up to one year in jail, a fine of up to $1,000, or both, and a retailer with a third violation within two years may face a court injunction barring kratom sales at that location for up to 180 days. The health department leads compliance, including unannounced inspections that may use participants under 21 under written-consent rules.
Rhode Island’s act also amends the state controlled substances statute to say the director of health has no authority to place or maintain mitragynine and 7-hydroxymitragynine in schedule I, which ties the regulatory framework to the state’s scheduling rules.
A few habits help when reading any kratom law. Check whether a bill was enacted, and which version: a Wyoming amendment filed during the session would have retitled the bill as a prohibition, but the enrolled act that reached the governor regulates sales, and the legislature’s history, as tracked by LegiScan, shows the governor signing it on March 6, 2026. Check effective dates, since both of these laws took or take effect months after enactment. And treat secondary summaries cautiously: website summaries of both laws vary, and some describe Wyoming’s bill as unenacted.
For readers following policy, the comparison shows that “regulation” can mean quite different things: a licensed, taxed supply chain in one state, a criminal-code framework with testing and inspections in another. Other states have chosen different paths, including outright prohibition, so the rules that apply depend on where a product is sold. Both laws are new, and the sources reviewed here do not evaluate how they affect consumer protection, product quality or access, so it is too early to draw conclusions about outcomes. What the texts do show is how lawmakers translate safeguards such as age limits, composition limits, testing and inspection into enforceable rules.